Thio-TEPA
CAS No. 52-24-4
Thio-TEPA ( NCI C01649; NSC 6396; Triethylenethiophosphoramide )
Catalog No. M14842 CAS No. 52-24-4
An alkylating agent used to treat cancer that has been previously used in the palliation of a wide variety of neoplastic diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 28 | In Stock |
|
10MG | 40 | In Stock |
|
25MG | 65 | In Stock |
|
50MG | 102 | In Stock |
|
100MG | 170 | In Stock |
|
200MG | 250 | In Stock |
|
500MG | 428 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThio-TEPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn alkylating agent used to treat cancer that has been previously used in the palliation of a wide variety of neoplastic diseases.
-
DescriptionAn alkylating agent used to treat cancer that has been previously used in the palliation of a wide variety of neoplastic diseases.Chemotherapeutic Agents Approved
-
SynonymsNCI C01649; NSC 6396; Triethylenethiophosphoramide
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNAAlkylation
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number52-24-4
-
Formula Weight189.22
-
Molecular FormulaC6H12N3PS
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESS=P(N1CC1)(N2CC2)N3CC3
-
Chemical NameAziridine, 1,1',1''-phosphinothioylidynetris-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Chloroambucil
Chlorambucil(WR-139013; CB-1348) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia.
-
Melflufen
Melflufen is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells.
-
Methyl methanesulfon...
Methyl methanesulfonate is a DNA alkylator that modifies adenine (3-methyladenine) and guanine (7-methyladenine) respectively, resulting in base mismatch and replication disorders.